Subscribe To
Progyny raises 2022 financial guidance
Shipments of Key Fertility Medication Have Resumed NEW YORK, Nov. 28, 2022 (GLOBE NEWSWIRE) — Progyny...
November 28, 2022, 1:00 pm
Progyny stock grows after fertility drug shipments resume, upping 4q guidance
Progyny Inc (NASDAQ:PGNY) announced that shipments of its fertility medication Menopur have resumed fol...
November 28, 2022, 11:28 am
Fertility manager progyny stock gains as resumption of menopur deliveries leads to raised guidance
Shares of Progyny Inc. PGNY, +0.17% gained 0.4% in premarket trading Monday, after the fertility benefi...
November 28, 2022, 8:16 am
Progyny, inc. (pgny) ceo peter anevski on q3 2022 results - earnings call transcript
Progyny, Inc. (NASDAQ:PGNY ) Q3 2022 Earnings Conference Call November 3, 2022 4:45 PM ET Company Parti...
November 4, 2022, 1:00 am
Progyny, inc. (pgny) ceo peter anevski on q2 2022 results - earnings call transcript
Progyny, Inc. (NASDAQ:PGNY ) Q2 2022 Earnings Conference Call August 4, 2022 4:45 PM ET Company Partici...
August 7, 2022, 8:00 am
Progyny: solving infertility problem
Progyny is a leading benefit management company that specializes in fertility and family building. Thei...
July 5, 2022, 1:35 pm
Todos medical says lab provista to launch uti pathogen pcr assay commercially
Todos Medical Ltd has said it is preparing for the commercial launch of a urinary tract infection (UTI) PCR assay after its lab Provista Diagnostics ...
June 13, 2022, 9:17 am
Progyny stock: a hidden gem tackling infertility
Progyny is a hidden gem tackling a prevalent and growing issue. With massive growth ahead and a solid c...
May 31, 2022, 1:26 pm
Progyny, inc. (pgny) ceo peter anevski on q1 2022 results - earnings call transcript
Progyny, Inc. (NASDAQ:PGNY ) Q1 2022 Earnings Call Transcript May 5, 2022 5:00 PM ET Company Representa...
May 5, 2022, 10:58 pm
Progyny: a profitable high-growth company
Incorporated in 2008, Progyny Inc. ( PGNY , Financial) is a leading benefits management company operati...
May 4, 2022, 6:21 pm
Evofem to present new research in gynecological health at the 2022 american college of obstetricians and gynecologists annual meeting
SAN DIEGO , April 26, 2022 /PRNewswire/ -- Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced it will present new data from the Phase 3 AMPO...
April 26, 2022, 8:46 am
Here's why you should retain hologic (holx) stock for now
Investors are optimistic about Hologic's (HOLX) robust international performance and strength in its gyn...
March 31, 2022, 10:32 am
Context therapeutics closes 2021 with balance sheet of nearly $50m
Context Therapeutics Inc said it closed 2021 with a balance sheet of nearly $50 million. As of December 31, 2021, the women's oncology company develo...
March 23, 2022, 4:34 pm
Progyny, inc. (pgny) ceo pete anevski on q4 2021 results - earnings call transcript
Progyny, Inc. (PGNY) CEO Pete Anevski on Q4 2021 Results - Earnings Call Transcript...
February 28, 2022, 9:55 pm
Progyny, inc. (pgny) ceo pete anevski on q4 2021 results - earnings call transcript
Progyny, Inc. (PGNY) CEO Pete Anevski on Q4 2021 Results - Earnings Call Transcript...
February 28, 2022, 9:55 pm
Progyny, inc. (pgny) ceo pete anevski on q4 2021 results - earnings call transcript
Progyny, Inc. (PGNY) CEO Pete Anevski on Q4 2021 Results - Earnings Call Transcript...
February 28, 2022, 9:55 pm
Progyny (pgny) surpasses q4 earnings estimates
Progyny (PGNY) delivered earnings and revenue surprises of 275% and 6.22%, respectively, for the quarte...
February 28, 2022, 7:53 pm
Progyny (pgny) surpasses q4 earnings estimates
Progyny (PGNY) delivered earnings and revenue surprises of 275% and 6.22%, respectively, for the quarte...
February 28, 2022, 7:53 pm
Progyny (pgny) surpasses q4 earnings estimates
Progyny (PGNY) delivered earnings and revenue surprises of 275% and 6.22%, respectively, for the quarte...
February 28, 2022, 7:53 pm
Context therapeutics prepares for a busy 2022 as it advances women's oncology treatments
If 2021 was a pivotal year for Context Therapeutics (NASDAQ:CNTX) Inc, 2022 promises to be even more so. Fresh from a US$31.25 million fundraise and...
February 23, 2022, 6:31 am